Best proffered paper less than 40

Abstract

Abstract: Toxicity and outcomes of ultra hypofractionation with stereotactic body radiation therapy for high risk and node positive prostate cancer Tejshri Telkhade, Jince Matthew, Tejaswi Kanala, Dipika Chourasia, Gitanjali Panigrahi, Rahul Krishnatry, Vedang Murthy Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India, E-mail: [email protected] Background: Stereotactic body radiotherapy (SBRT) in low and intermediate risk prostate cancer has shown encouraging results, however its use in high-risk patients is limited due to lack of data regarding radiotherapy dose, pelvic nodal treatment and androgen deprivation therapy (ADT). Preliminary outcome Trinanjan Basu, Bhavya Patineedi, Hirak Vyaas, Indoo Ambulkar, Deepika Nayek, Satish Rao, Upasna Saxena, Shankar Vangipuram Department of Radiation Oncology, Medical and Surgical Oncology, HCG Cancer Centre, Mumbai, Maharashtra, India, E-mail: [email protected] Purpose and Objective: To evaluate early clinical results from a uniform protocol of adaptive modulated simultaneous integrated boost (SIB) chemoradiation (CRT) as definite treatment for non-metastatic locally advanced squamous cell carcinoma of head and neck (SCHNC). First surveillance PETCT was between 10-14 weeks post CRT. At 1st follow up complete response (CR) at primary site was 85% on both FOL and PETCT (Hopkins score 1-2). [...]last follow up 60% had complete response, 16% had loco-regional failure and 2% distant metastases.